Factors like emergence of technologically advanced stent products, persistently escalating geriatric population and the feasibility of even drug eluting stents (DES) in them and the numerous acquisitions and distribution agreements among the stent companies are further substantiating enormous growth opportunities of the market.
An increase in the adoption of minimally invasive surgeries, rapid growth in the aging population, growing number of cosmetic surgeries, the prevalence of obesity and its related surgeries, the advancement in technology, and demand for electrosurgical procedures in emerging regions are driving the growth.
Some of the factors driving the market are increase in incidence and prevalence of osteoporosis, osteoarthritis, degenerative disc disease, herniated disc, scoliosis, kyphosis, lordosis, Ankylosing spondylitis, sacroiliac joint dysfunction, and, sports injuries, trauma, or abnormal anatomical developments leading to chronic disability and increase in the aging population, technological advancement, and acquisitions.
The factors such as rising incidences of respiratory diseases, rapid growth in the geriatric population requiring long term ventilation, increase in the number of premature birth and the emergence of the COVID-19 pandemic are the factors driving the market growth.
Some of the factors driving the market are increase in incidence and prevalence of neurovascular diseases like cerebral aneurysm, stroke, arteriovenous malformations, and increase in the aging population, technological advancement, acquisitions and favourable reimbursements.
An increasing number of patients suffering from obesity and the rise in the aging population who are vulnerable to develop hernia, rising adoption of tension-free repair procedures and increasing demand for minimally invasive procedures, are driving the growth of hernia repair devices market.
Increasing prevalence of infectious diseases, requirement of early detection of infectious disease, increasing point of care diagnostics and rapid diagnostics, favourable reimbursements, technological advancements and rising investments in diagnostics are driving the market
Some of the factors such as increasing population prone to aging-related medical conditions, increasing R&D spending for developing innovative and technologically advanced products, and also the development of more personalized products for greater patient comfort and care are driving the market growth
The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth
Increasing expanded indication approval for various transcatheter structural heart products, persistently increasing geriatric population burdened with various kinds of degenerative valvular hear diseases, increasing demand for highly efficient, minimally invasive structural heart therapeutic products from the value centric patient population, increasing R&D spending for developing innovative and technologically advanced products, growing economies and increasing demand for better healthcare facilities in emerging markets
Increasing prevalence of different types of cancers, increasing awareness of personalized medicine, national program for cancer control by individual countries, availability of companion diagnostics, growth in the point of care testing, increase in sequencing-based tests and other molecular and immunology based techniques are driving the growth of cancer diagnostics